Short communication: Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor in advanced brain tumor patients: Preliminary study
- T. Crombet
- , N. Iznaga
- , R. Pérez
- , A. Lage
- , O. Torres
- , V. Rodríguez
- , A. Menéndez
- , A. Stevenson
- , M. Ramos
- , F. Torres
- , R. Figueredo
- , I. Veitía
Research output: Contribution to journal › Article › peer-review
54
Scopus
citations